Home/Filings/4/0001878894-21-000009
4//SEC Filing

Miller Joseph M 4

Accession 0001878894-21-000009

CIK 0001534120other

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 4:42 PM ET

Size

5.2 KB

Accession

0001878894-21-000009

Insider Transaction Report

Form 4
Period: 2021-09-30
Miller Joseph M
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-09-30+6,9396,939 total
    Exercise: $2.18From: 2021-09-30Exp: 2031-09-30Common Stock (6,939 underlying)
Footnotes (1)
  • [F1]100% of this stock option will immediately vest on the date that it is granted.

Issuer

Avalo Therapeutics, Inc.

CIK 0001534120

Entity typeother

Related Parties

1
  • filerCIK 0001746372

Filing Metadata

Form type
4
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:42 PM ET
Size
5.2 KB